AliveDx Suisse S.A. and Tabrane Pharmaceuticals (PVT) Limited have signed a distribution agreement, which will enable Tabrane Pharmaceuticals to distribute the MosaiQ® solution in Sri Lanka. The distribution agreement takes effect immediately.
AliveDx is dedicated to expanding its reach and presence across various regions and committed to creating clinical and economical value for clinicians, helping them to shorten the time to diagnosis. This strategic collaboration with an important partner in Sri Lanka is a testimony to the company’s commitment to supporting the healthcare sector and enhancing patient care.
The MosaiQ platform simplifies workflows and creates efficiencies thanks to its multiplexing microarray assay technology. This streamlined and efficient approach offers faster and more cost-effective solutions to healthcare providers and patients alike.
“We are excited to partner with Tabrane Pharmaceuticals. Partnering with such a strong player in the APAC market will allow us to take a strategic role in improving patients’ lives in the region,” said Manuel O. Méndez, CEO of AliveDx.
Tabrane Pharmaceuticals is a pharmaceutical wholesale distributor in Sri Lanka. With a clear understanding of Sri Lanka’s medical distribution business and deep insight into patient and healthcare professional needs, Tabrane Pharmaceuticals is committed to investing in customer training, education, and clinical evaluation support; ensuring the delivery of quality products and services with the highest integrity; and growing together with their business partners and customers.
“We are honored to collaborate with AliveDx. Including their solutions in our portfolio marks a significant step in our expansion into the IVD domain. We believe that the MosaiQ solution will empower us to bring the latest, best-in-class technologies to Sri Lanka’s healthcare sector, ultimately making a positive impact on patient care,” said Mr. Dulip Jayawardana, Chairman of Tabrane Pharmaceuticals.
To learn more, please visit the Tabrane Pharmaceuticals website.